SCHEMBL21595963

SCHEMBL21595963

CNC(=O)OCCOc1ccc(F)cc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
MAPT P10636 2/20 0.56
GAA P10253 1/20 0.56
FAAH O00519 3/20 0.51
LMNA P02545 1/20 0.49
TP53 P04637 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
KDM4E B2RXH2 1/20 0.48
NPC1 O15118 1/20 0.47
TSHR P16473 1/20 0.47
RAB9A P51151 1/20 0.47
LTA4H P09960 2/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
PLK1 P53350 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10878950 0.95 MEN1 (0.57) MEN1KMT2AMAPTGAAFAAH
SCHEMBL21595691 0.85 LMNA (0.66) MEN1KMT2AMAPTLMNATP53
SCHEMBL14102238 0.85 L3MBTL1 (0.54) MEN1KMT2AMAPTLMNATP53
SCHEMBL21595884 0.83 CYP1A2 (0.50) MEN1KMT2AMAPTLMNATP53
SCHEMBL20874025 0.83 LMNA (0.49) MEN1KMT2AMAPTLMNATP53
SCHEMBL21595781 0.83 CHRNB2 (0.49) MEN1KMT2AMAPTGAAFAAH
SCHEMBL7993485 0.83 RAB9A (0.68) MEN1KMT2AMAPTLMNATP53
SCHEMBL21595906 0.81 KMT2A (0.43) MEN1KMT2AMAPTGAALMNA
SCHEMBL21595783 0.81 MRGPRX4 (0.47) MEN1KMT2AMAPTGAALMNA
SCHEMBL21595643 0.81 ALDH1A1 (0.60) MAPTLMNATP53SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019244066-A2 PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV Healthcare UK (No.5) Limited (GB) 2019-12-26 WO disclosed